Page last updated: 2024-09-05

erlotinib hydrochloride and Aging

erlotinib hydrochloride has been researched along with Aging in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashinuma, H; Sekine, I	1
Belum, VR; Bölke, E; Buhren, BA; Gerber, PA; Hevezi, P; Homey, B; Jänicke, RU; Lacouture, ME; Robert, C; Schrumpf, H; Sohn, D	1
Alexandre, J; Arrondeau, J; Bigot, F; Blanchet, B; Boudou-Rouquette, P; Cessot, A; Chapron, J; Goldwasser, F; Huillard, O; Thomas-Schoemann, A; Tlemsani, C; Vidal, M	1
Lin, CC; Yang, CH	1

Reviews

1 review(s) available for erlotinib hydrochloride and Aging

Article	Year
Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer. Targeted oncology, 2009, Volume: 4, Issue:1 Topics: Age Factors; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Neoplasm Staging; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome	2009

Article

Year

Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer.

Targeted oncology, 2009, Volume: 4, Issue:1

Topics: Age Factors; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Neoplasm Staging; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome

2009

Trials

1 trial(s) available for erlotinib hydrochloride and Aging

Article	Year
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old. Investigational new drugs, 2017, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Agents; Body Height; Body Mass Index; Body Weight; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors	2017

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Aging

Article	Year
[Targeted therapy for solid tumors in the elderly]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:8 Topics: Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Breast Neoplasms; Cetuximab; Colonic Neoplasms; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Male; Molecular Targeted Therapy; Protein Kinase Inhibitors; Quinazolines; Trastuzumab	2015
Mechanisms of skin aging induced by EGFR inhibitors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:10 Topics: Aged; Aged, 80 and over; Aging; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Retrospective Studies; Skin Aging; Skin Diseases	2016

Article

Year

[Targeted therapy for solid tumors in the elderly].

Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:8

Topics: Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Breast Neoplasms; Cetuximab; Colonic Neoplasms; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Male; Molecular Targeted Therapy; Protein Kinase Inhibitors; Quinazolines; Trastuzumab

2015

Mechanisms of skin aging induced by EGFR inhibitors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:10

Topics: Aged; Aged, 80 and over; Aging; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Retrospective Studies; Skin Aging; Skin Diseases

2016